Initiation of HAART at Higher CD4 Cell Counts Is Associated With a Lower Frequency of Antiretroviral Drug Resistance Mutations at Virologic Failure

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Acquired Immune Deficiency Syndromes

• Publication date

  2009-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/QAI.0b013e3181acb630PMID 19474757
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies

  2009cited by this paper
• Effect of early versus deferred antiretroviral therapy for HIV on survival.

  2009cited by this paper
• The new england journal of medicine Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival

  2009cited by this paper
• Update of the Drug Resistance Mutations in HIV-1.

  2008cited by this paper
• Initiation of Antiretroviral Therapy at CD4 Cell Counts ≥350 Cells/mm3 Does Not Increase Incidence or Risk of Peripheral Neuropathy, Anemia, or Renal Insufficiency

  2008cited by this paper
• Risk of extensive virological failure to the three original antiretroviral drug classes over long-term follow-up from the start of therapy in patients with HIV infection: an observational cohort study.

  2007cited by this paper
• Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies

  2007cited by this paper
• Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study

  2006cited by this paper
• Update of the drug resistance mutations in HIV-1: Fall 2006.

  2006cited by this paper

• A Retrospective Analysis Exploring the Impact of Psychiatric Comorbidities on the Time to Initiate HIV Treatment

  2025cites this paper
• Social Support Mitigates Negative Impact of Food Insecurity on Antiretroviral Adherence Among Postpartum Women in Western Kenya

  2020cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV

  2020cites this paper
• When to Initiate Antiretroviral Therapy, With Protocol for Rapid Initiation

  2020cites this paper
• Epidemiologic and viral predictors of antiretroviral drug resistance among persons living with HIV in a large treatment program in Nigeria

  2020cites this paper
• Tenofovir and Emtricitabine Resistance among Antiretroviral-Naive Patients in the Canadian Observational Cohort Collaboration: Implications for PrEP

  2019cites this paper
• Primary health care: an opportunity for early identification of people living with undiagnosed HIV infection

  2019cites this paper
• Prevalence of antiretroviral therapy treatment failure among HIV-infected pregnant women at first antenatal care: PMTCT Option B+ in Malawi

  2018cites this paper
• Diagnosis and Management of Acute HIV

  2018cites this paper
• Moving forward with treatment options for HIV-infected children

  2018cites this paper
• Late presenters among newly diagnosed HIV-infected in Poland in 2006-2008

  2017cites this paper
• Effect of immediate initiation of antiretroviral treatment on the risk of acquired HIV drug resistance

  2017cites this paper
• HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

  2017cites this paper
• Evolução clínica e laboratorial das crianças e adolescentes com HIV/AIDS após falha terapêutica orientada pela genotipagem

  2017cites this paper
• Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV

  2017cites this paper
• Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis.

  2017cites this paper
• Retention in care, viral suppression, treatment adherence and quality of life in a public antiretroviral therapy program in Addis Ababa, Ethiopia

  2016cites this paper
• Challenges in initiating antiretroviral therapy for all HIV-infected people regardless of CD4 cell count

  2016cites this paper
• Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

  2016cites this paper
• High Level of Virological Suppression among HIV-Infected Adults Receiving Combination Antiretroviral Therapy in Addis Ababa, Ethiopia

  2016cites this paper
• Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

  2016cites this paper
• Evaluation of HIV testing recommendations in specialty guidelines for the management of HIV indicator conditions

  2016cites this paper
• Antiretroviral Therapy: When to Start

  2015cites this paper
• Virological failure and development of new resistance mutations according to CD4 count at combination antiretroviral therapy initiation

  2015cites this paper
• HIV-1 Treatment-as-Prevention

  2015cites this paper
• Initiation of antiretroviral therapy at high CD4+ cell counts is associated with positive treatment outcomes

  2015cites this paper
• Evolving Human Rights and the Science of Antiretroviral Medicine.

  2015cites this paper
• Knowledge, Attitude and Practice of Antiretroviral Therapy among Adult HIV Patients Attending a Tertiary Hospital in Nigeria

  2015cites this paper
• CD4+ T cell counts in initiation of antiretroviral therapy in HIV infected asymptomatic individuals; controversies and inconsistencies.

  2015cites this paper
• Antiretroviral therapy: when to start.

  2014cites this paper
• The Cost of Antiretroviral Drug Resistance in HIV-Positive Patients

  2014cites this paper
• Biomarkers for tuberculosis in the context of HIV/AIDS in Ethiopia

  2014cites this paper
• Using CD4 Percentage and Age to Optimize Pediatric Antiretroviral Therapy Initiation

  2014cites this paper
• Etude de l’établissement des réservoirs VIH lors de la primo-infection et de l’impact des traitements antirétroviraux très précoces sur ces réservoirs

  2014cites this paper
• A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City.

  2014cites this paper
• Virological Outcomes and Drug Resistance in Chinese Patients after 12 Months of 3TC-Based First-Line Antiretroviral Treatment, 2011–2012

  2014cites this paper
• When to start antiretroviral therapy: as soon as

  2013cites this paper
• When to start antiretroviral therapy: as soon as possible

  2013cites this paper
• Feasibility and Effectiveness of Indicator Condition-Guided Testing for HIV: Results from HIDES I (HIV Indicator Diseases across Europe Study)

  2013cites this paper
• Benefits of Antiretroviral Therapy Reduction in Mortality and / or AIDS-Related Morbidity According to Pretreatment CD 4 Cell Count

  2013cites this paper
• Initiation of Antiretroviral Therapy in Youth with HIV: A U.S.-Based Provider Survey

  2013cites this paper
• Fifteen million people on antiretroviral treatment by 2015: treatment as prevention

  2013cites this paper
• Evaluation of the impact of immediate versus WHO recommendations-guided antiretroviral therapy initiation on HIV incidence: the ANRS 12249 TasP (Treatment as Prevention) trial in Hlabisa sub-district, KwaZulu-Natal, South Africa: study protocol for a cluster randomised controlled trial

  2013cites this paper
• Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review.

  2013cites this paper
• Role of HIV Infection Duration and CD4 Cell Level at Initiation of Combination Anti-Retroviral Therapy on Risk of Failure

  2013cites this paper
• Treatment-for-prevention: clinical considerations.

  2012cites this paper
• Efficacy of 1998 Vs 2006 First-Line Antiretroviral Regimens for HIV Infection: An Ordinary Clinics Retrospective Investigation

  2012cites this paper
• Should We Treat Acute HIV Infection?

  2012cites this paper
• The HIV Epidemic in the USA: Current Trends, 2010

  2012cites this paper
• Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy

  2012cites this paper
• Antiretroviral Therapy for Prevention of Tuberculosis in Adults with HIV: A Systematic Review and Meta-Analysis

  2012cites this paper
• The pattern of immunologic and virologic responses to Highly Active Antiretroviral Treatment (HAART): does success bring further challenges?

  2011cites this paper
• The 2010 South African guidelines for the management of HIV and AIDS: a review.

  2011cites this paper
• Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa.

  2011cites this paper
• Responses to highly active antiretroviral therapy and clinical events in patients with a low CD4 cell count: late presenters vs. late starters

  2011cites this paper
• Some patient-related factors associated with late access to ART in China's free ART program

  2011cites this paper
• The Role of Toxicity-Related Regimen Changes in the Development of Antiretroviral Resistance

  2011cites this paper
• Crippling of HIV at Multiple Stages with Recombinant Adeno-Associated Viral Mediated RNA Interference

  2011cites this paper
• Antiretroviral therapy in Indian setting: When & what to start with, when & what to switch to?

  2011cites this paper
• Modelling the Impact of Antiretroviral Therapy on the Epidemic of HIV

  2011cites this paper
• Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options

  2010cites this paper
• CD4 T Cell Assessments in Evaluation of HIV Therapeutics

  2010cites this paper
• Epidemiology of HIV in the United States

  2010cites this paper
• Diagnosis and management of antiretroviral-therapy failure in resource-limited settings in sub-Saharan Africa: challenges and perspectives.

  2010cites this paper
• Evaluation of Oral Health Status as an Indicator of Disease Progression in HIV Positive Children

  2010cites this paper
• When to start antiretroviral therapy in adults in low- and middle-income countries: science and practice

  2010cites this paper
• The HIV-Infected Adolescent

  2010cites this paper
• Nevirapine‐associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya

  2010cites this paper
• HAART during pregnancy and during breastfeeding among HIV-infected women in the developing world: has the time come?

  2009cites this paper
• Clinical case definition and manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome

  2009cites this paper
• Another Benefit to Starting ART Early: Lower Risk for Resistance

  2009cites this paper
• When to Initiate ART

  2008cites this paper
• Diagnosis and management of acute HIV infection.

  2007cites this paper
• Initiation of Antiretroviral Therapy

  year unknowncites this paper